232 related articles for article (PubMed ID: 36436735)
1. Photodynamic therapy with zinc phthalocyanine enhances the anti-cancer effect of tamoxifen in breast cancer cell line: Promising combination treatment against triple-negative breast cancer?
Rajabi N; Mohammadnejad F; Doustvandi MA; Shadbad MA; Amini M; Tajalli H; Mokhtarzadeh A; Baghbani E; Silvestris N; Baradaran B
Photodiagnosis Photodyn Ther; 2023 Mar; 41():103212. PubMed ID: 36436735
[TBL] [Abstract][Full Text] [Related]
2. Photodynamic Therapy with Zinc Phthalocyanine Inhibits the Stemness and Development of Colorectal Cancer: Time to Overcome the Challenging Barriers?
Gholizadeh M; Doustvandi MA; Mohammadnejad F; Shadbad MA; Tajalli H; Brunetti O; Argentiero A; Silvestris N; Baradaran B
Molecules; 2021 Nov; 26(22):. PubMed ID: 34833970
[TBL] [Abstract][Full Text] [Related]
3. Photodynamic therapy using zinc phthalocyanine with low dose of diode laser combined with doxorubicin is a synergistic combination therapy for human SK-MEL-3 melanoma cells.
Doustvandi MA; Mohammadnejad F; Mansoori B; Tajalli H; Mohammadi A; Mokhtarzadeh A; Baghbani E; Khaze V; Hajiasgharzadeh K; Moghaddam MM; Hamblin MR; Baradaran B
Photodiagnosis Photodyn Ther; 2019 Dec; 28():88-97. PubMed ID: 31454716
[TBL] [Abstract][Full Text] [Related]
4. The interaction between the light source dose and caspase-dependent and -independent apoptosis in human SK-MEL-3 skin cancer cells following photodynamic therapy with zinc phthalocyanine: A comparative study.
Doustvandi MA; Mohammadnejad F; Mansoori B; Mohammadi A; Navaeipour F; Baradaran B; Tajalli H
J Photochem Photobiol B; 2017 Nov; 176():62-68. PubMed ID: 28964887
[TBL] [Abstract][Full Text] [Related]
5. A Triple Combination of Metformin, Acetylsalicylic Acid, and Oseltamivir Phosphate Impacts Tumour Spheroid Viability and Upends Chemoresistance in Triple-Negative Breast Cancer.
Sambi M; Samuel V; Qorri B; Haq S; Burov SV; Markvicheva E; Harless W; Szewczuk MR
Drug Des Devel Ther; 2020; 14():1995-2019. PubMed ID: 32546966
[TBL] [Abstract][Full Text] [Related]
6. In silico analysis of the association of hsa-miR-16 expression and cell survival in MDA-MB-231 breast cancer cells subjected to photodynamic therapy.
Cupido-Sánchez MG; Herrera-González NE; Mendoza CCB; Hernández MLM; Ramón-Gallegos E
Photodiagnosis Photodyn Ther; 2021 Mar; 33():102106. PubMed ID: 33217568
[TBL] [Abstract][Full Text] [Related]
7. Attritional evaluation of lipophilic and hydrophilic metallated phthalocyanines for oncological photodynamic therapy.
Dias LM; Sharifi F; de Keijzer MJ; Mesquita B; Desclos E; Kochan JA; de Klerk DJ; Ernst D; de Haan LR; Franchi LP; van Wijk AC; Scutigliani EM; Cavaco JEB; Tedesco AC; Huang X; Pan W; Ding B; Krawczyk PM; Heger M;
J Photochem Photobiol B; 2021 Mar; 216():112146. PubMed ID: 33601256
[TBL] [Abstract][Full Text] [Related]
8. Development of targeted photodynamic therapy drugs by combining a zinc phthalocyanine sensitizer with TSPO or EGFR binding groups: the impact of the number of targeting agents on biological activity.
Toubia I; Nguyen C; Diring S; Onofre M; Daurat M; Gauthier C; Gary-Bobo M; Kobeissi M; Odobel F
Org Biomol Chem; 2023 Aug; 21(32):6509-6523. PubMed ID: 37341568
[TBL] [Abstract][Full Text] [Related]
9. Tetra-triethyleneoxysulfonyl substituted zinc phthalocyanine for photodynamic cancer therapy.
Kuzyniak W; Ermilov EA; Atilla D; Gürek AG; Nitzsche B; Derkow K; Hoffmann B; Steinemann G; Ahsen V; Höpfner M
Photodiagnosis Photodyn Ther; 2016 Mar; 13():148-157. PubMed ID: 26162500
[TBL] [Abstract][Full Text] [Related]
10. Anti-Psoriasis Effects and Mechanisms of Α-(8-Quinolinoxy) Zinc Phthalocyanine-Mediated Photodynamic Therapy.
Liu HQ; Wang YM; Li WF; Li C; Jiang ZH; Bao J; Wei JF; Jin HT; Wang AP
Cell Physiol Biochem; 2017; 44(1):200-214. PubMed ID: 29131032
[TBL] [Abstract][Full Text] [Related]
11. Novel zinc phthalocyanine as a promising photosensitizer for photodynamic treatment of esophageal cancer.
Kuzyniak W; Schmidt J; Glac W; Berkholz J; Steinemann G; Hoffmann B; Ermilov EA; Gürek AG; Ahsen V; Nitzsche B; Höpfner M
Int J Oncol; 2017 Mar; 50(3):953-963. PubMed ID: 28098886
[TBL] [Abstract][Full Text] [Related]
12. Indocyanine green loaded liposome nanocarriers for photodynamic therapy using human triple negative breast cancer cells.
Shemesh CS; Hardy CW; Yu DS; Fernandez B; Zhang H
Photodiagnosis Photodyn Ther; 2014 Jun; 11(2):193-203. PubMed ID: 24657627
[TBL] [Abstract][Full Text] [Related]
13. Combination of verteporfin-photodynamic therapy with 5-aza-2'-deoxycytidine enhances the anti-tumour immune response in triple negative breast cancer.
Banerjee SM; Acedo P; El Sheikh S; Harati R; Meecham A; Williams NR; Gerard G; Keshtgar MRS; MacRobert AJ; Hamoudi R
Front Immunol; 2023; 14():1188087. PubMed ID: 38022682
[TBL] [Abstract][Full Text] [Related]
14. Development and in vitro proof-of-concept of interstitially targeted zinc- phthalocyanine liposomes for photodynamic therapy.
Broekgaarden M; de Kroon AI; Gulik TM; Heger M
Curr Med Chem; 2014; 21(3):377-91. PubMed ID: 23931271
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy of hepatocellular carcinoma using tetra-triethyleneoxysulfonyl zinc phthalocyanine as photosensitizer.
Ogbodu RO; Nitzsche B; Ma A; Atilla D; Gürek AG; Höpfner M
J Photochem Photobiol B; 2020 Jul; 208():111915. PubMed ID: 32480203
[TBL] [Abstract][Full Text] [Related]
16. A tumor-targeted Ganetespib-zinc phthalocyanine conjugate for synergistic chemo-photodynamic therapy.
Huang L; Wei G; Sun X; Jiang Y; Huang Z; Huang Y; Shen Y; Xu X; Liao Y; Zhao C
Eur J Med Chem; 2018 May; 151():294-303. PubMed ID: 29627724
[TBL] [Abstract][Full Text] [Related]
17. Novel piperazine-substituted silicon phthalocyanines exert anti-cancer effects against breast cancer cells.
Nalçaoğlu A; Sarı C; Değirmencioğlu İ; Eyüpoğlu FC
Photodiagnosis Photodyn Ther; 2022 Mar; 37():102734. PubMed ID: 35066132
[TBL] [Abstract][Full Text] [Related]
18. Co-encapsulation of sodium diethyldithiocarbamate (DETC) and zinc phthalocyanine (ZnPc) in liposomes promotes increases phototoxic activity against (MDA-MB 231) human breast cancer cells.
Feuser PE; Cordeiro AP; de Bem Silveira G; Borges Corrêa MEA; Lock Silveira PC; Sayer C; de Araújo PHH; Machado-de-Ávila RA; Dal Bó AG
Colloids Surf B Biointerfaces; 2021 Jan; 197():111434. PubMed ID: 33166932
[TBL] [Abstract][Full Text] [Related]
19. ABCG2 transporter inhibitor restores the sensitivity of triple negative breast cancer cells to aminolevulinic acid-mediated photodynamic therapy.
Palasuberniam P; Yang X; Kraus D; Jones P; Myers KA; Chen B
Sci Rep; 2015 Aug; 5():13298. PubMed ID: 26282350
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and characterization of novel Schiff base-silicon (IV) phthalocyanine complex for photodynamic therapy of breast cancer cell lines.
Sarı C; Değirmencioğlu İ; Eyüpoğlu FC
Photodiagnosis Photodyn Ther; 2023 Jun; 42():103504. PubMed ID: 36907257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
